| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/02/2003 | US20030004348 Difluoro-diamine methylene derivatives |
| 01/02/2003 | US20030004202 Endothelin receptor antagonists |
| 01/02/2003 | US20030004196 Antiinflamamtory agents; autoimmune disease |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | EP1271581A2 Electrolyte composition, photoelectric conversion device and photo-electrochemical cell |
| 01/02/2003 | EP1271240A2 Silver halide color photographic material |
| 01/02/2003 | EP1270559A1 Novel imidazole derivatives with anti-inflammatory activity |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1268441A1 An intermediate and process for its synthesis |
| 01/02/2003 | EP1268440A1 Imidazole carbenes |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1268401A1 Process for the selective n-formylation of n-hydroxylamines |
| 01/02/2003 | EP1268399A2 Method for separating a basic amino acid from fermentation broth |
| 01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
| 01/02/2003 | EP1268371A1 Novel late transition metal catalyst complexes and oligomers therefrom |
| 01/02/2003 | EP1268368A2 Catalytic asymmetric desymmetrization of meso compounds |
| 01/02/2003 | EP1268051A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 01/02/2003 | EP1083897A4 Hiv integrase inhibitors |
| 01/02/2003 | EP1019370B1 Ace-inhibitor nitric salts |
| 01/02/2003 | EP0915859B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/01/2003 | CN1388122A Prepn of bromochlorodimethyl hydantoin as disinfectant |
| 01/01/2003 | CN1387846A Intraocular pressure reducing agent |
| 12/31/2002 | US6501000 Late transition metal catalyst complexes and oligomers therefrom |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/27/2002 | WO2002102742A2 Method for the catalytic oxidative separation of cyclic saturated and unsaturated compounds |
| 12/27/2002 | WO2002102375A2 Imidazole derivatives for modulating sodium channels |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/27/2002 | CA2449916A1 Imidazole derivatives for modulating sodium channels |
| 12/26/2002 | US20020198426 Contacting the cyclic olefin with the second olefinic reactant in the presence of a catalyst composed of a Group 8 transition metal alkylidene complex under conditions and for a time period effective to allow the ROCM reaction to occur |
| 12/26/2002 | US20020198376 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis |
| 12/26/2002 | US20020198237 2,5-substituted imidazole compounds useful as histamine H3 receptor mediators |
| 12/26/2002 | US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/26/2002 | US20020198115 Thiohydantoin derivative, dithiophosphate |
| 12/25/2002 | CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists |
| 12/25/2002 | CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498180 Such as 2-(3'-hydroxymethyl-2'-carboxycyclopropyl)glycine; modulating metabotropic glutamate receptor; treating disorders of central nervous |
| 12/24/2002 | US6498172 Prostaglandin agonists and their use to treat bone disorders |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002101182A2 Solvent extraction mixture comprising substituted imidazole or benzimidazole for the separation of groups of base metals |
| 12/19/2002 | WO2002101101A2 Solvent extraction mixture comprising substituted imidazole or benzimidazole for the purification of base metals |
| 12/19/2002 | WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/19/2002 | WO2002100834A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 12/19/2002 | WO2002100819A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | WO2002100414A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence |
| 12/19/2002 | WO2002100410A1 Methods of treating alzheimer's disease |
| 12/19/2002 | WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 12/19/2002 | WO2002100368A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 12/19/2002 | WO2002100365A1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002100327A2 Substituted 1-benzazepines and derivatives thereof |
| 12/19/2002 | WO2002100172A1 Administration of agents via the pept-2 transporter |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
| 12/19/2002 | WO2002063957A3 Selective substituted aryl ketone and safener based herbicides |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands |
| 12/19/2002 | US20020193414 Adamantane derivatives |
| 12/19/2002 | US20020193411 Pesticidal 1-polyarylpyrazoles |
| 12/19/2002 | US20020193283 Inhibitors of prenyl-protein transferase |
| 12/19/2002 | US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 12/19/2002 | DE10129117A1 Catalytic oxidative cleavage of saturated and unsaturated cyclic compounds to form non-cyclic compounds comprises use of heterocyclic catalyst and acid cocatalyst |
| 12/19/2002 | DE10129057A1 Verbessertes Verfahren zur Herstellung kernfluorierter Aromaten Improved process for preparing aromatic kernfluorierter |
| 12/19/2002 | DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them |
| 12/19/2002 | CA2449957A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence |
| 12/19/2002 | CA2449948A1 Methods of treating alzheimer's disease |
| 12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | CA2448764A1 N-arylphenylacetamide derivatives and pharmaceutical compositions containing the same |
| 12/19/2002 | CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 12/19/2002 | CA2447687A1 Substituted 1-benzazepines and derivatives thereof |
| 12/18/2002 | EP1267369A2 Pyridine compound, its use as charge transfer material, and photoelectrochemical cell |
| 12/18/2002 | EP1266904A1 Improved process for preparing fluorinated aromatic compounds |
| 12/18/2002 | EP1266897A2 Hypoglycemic imidazoline compounds |
| 12/18/2002 | EP1265902A1 Method for producing sulfonyl imidazole derivatives by phase transfer catalysis |
| 12/18/2002 | EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 12/18/2002 | EP1265869A2 N-halamine vinyl compounds and their polymeric biocides |
| 12/18/2002 | EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 12/18/2002 | EP1265861A2 Benzylated pde4 inhibitors |
| 12/18/2002 | EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265855A1 Novel cd23 inhibitors |
| 12/18/2002 | EP1265828A1 Method for reducing organic compounds in a microreactor by means of hydrides and/or the derivatives thereof |
| 12/18/2002 | EP1086101B1 Beta-carboline compounds |
| 12/17/2002 | US6495699 Antiarthritic agents; osteoporosis |
| 12/17/2002 | US6495698 Binder-free compacted forms of 1,3-dihalo-5,5-dimethylhydantoins |
| 12/17/2002 | US6495693 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 12/17/2002 | US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine |
| 12/17/2002 | US6495584 Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 12/17/2002 | US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 12/17/2002 | US6495573 Non-systemic control of parasites |
| 12/17/2002 | US6495569 Chemokine antagonists; treating disease associated with inflammation and/or pathogenic leukocyte recruitment and/or activation |
| 12/17/2002 | US6495567 Triaryl methane compounds and their use in the treatment of diarrhea and scours |